NCT01442272

Value Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin D

Clinical Trial, Open, Parallel Groups , Value the Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin D

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 174 (estimated)
• Sponsor: Hospital Universitario de Canarias · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine the value the additional antiproteinuric effects of vitamin D derivatives treatment, in patients with Chronic Kidney Illness phase II-IV, with lack of vitamin D and residual proteinuria higher 0,5 grams/day.

Conditions

• Kidney Failure, Chronic
• Disorder of Vitamin D

Interventions

Type	Name	Description
DRUG	Hidroferol®	Hidroferol® drinkable ampoule in oral solution, 266 mcg (1 drinkable ampoule) each 15 days during 12 months
DRUG	Paricalcitol: Zemplar®	Paricalcitol (Zemplar®) oral capsule , 1 mcg (1 capsule)each 24 hours during 12 months
DRUG	Habitual medication	Habitual medication

Timeline

• Start date: 2012-01-01
• Primary completion: 2012-10-01
• Completion: 2013-10-01
• First posted: 2011-09-28
• Last updated: 2012-05-21

Locations

2 sites across 1 country: Spain